CagriSema vs Semaglutide: Why Magnesium Levels Determine Your GLP-1 GI Tolerability
CagriSema emerges in 2026 as the potent dual-agonist successor to Semaglutide, clinical data from the REDEFINE trials reveals a significant uptick in gastrointestinal sensitivity due to the combined slowing effects…